Frazier Life Sciences VIII, L.P. has an estimated net worth of $67 Million. This is based on reported shares across multiple companies, which include ALPINE IMMUNE SCIENCES, INC., Arcutis Biotherapeutics, Inc., Sierra Oncology, Inc., Entasis Therapeutics Holdings Inc., and Aptinyx Inc..

2018 was Frazier Life Sciences VIII, L.P.'s most active year for acquiring shares with 8 total transactions. Frazier Life Sciences VIII, L.P.'s most active month to acquire stocks was the month of January. 2020 was Frazier Life Sciences VIII, L.P.'s most active year for disposing of shares, totalling 4 transactions. Frazier Life Sciences VIII, L.P.'s most active month to dispose stocks was the month of August. 2020 saw Frazier Life Sciences VIII, L.P. paying a total of $8,500,000.00 for 10,033,758 shares, this is the most they've acquired in one year. In 2020 Frazier Life Sciences VIII, L.P. cashed out on 9,583,758 shares for a total of $250,010.00, their largest year based on trade value.